Is imatinib a prototypical example of targeted drug therapy? - Wikidata - wikimedia - TriplyDB

Is imatinib a prototypical example of targeted drug therapy?

Is imatinib a prototypical example of targeted drug therapy?

http://www.wikidata.org/entity/Q38819072

about

Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery.

P2860

Q39169235-1568F128-73F9-43A7-837D-2E674EB74A74

P2860

Is imatinib a prototypical example of targeted drug therapy?

http://www.wikidata.org/entity/Q38819072

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Is imatinib a prototypical example of targeted drug therapy?

@en

type

label

Is imatinib a prototypical example of targeted drug therapy?

@en

prefLabel

Is imatinib a prototypical example of targeted drug therapy?

@en

P1433

Q38819072-14C87011-CA2D-495A-A631-A99BA382BD24

P1476

Q38819072-1E408755-D671-4713-BBB8-CC6BE9FA8404

P2093

Q38819072-868084A3-C5E6-46A3-AFB1-81C1E09ABE3F

P2860

Q38819072-04EEE501-4368-4AA6-AA22-902BC8B9CDF9

Q38819072-155D262D-9099-441C-A44E-2FDA6581425C

Q38819072-3EB1BC4B-61F4-4E39-ACC7-52D294F45185

Q38819072-4EE590DE-9C32-43C7-8423-2AEDEAE27FBC

Q38819072-57E84F38-EDBF-416C-B0A2-6A5524F2C808

Q38819072-5D08FBE4-E7D1-4AEF-AC42-CAF6326E2904

Q38819072-63760F67-AD07-4B0D-8793-4541F8AB3499

Q38819072-761A987D-18B6-49A4-9A6D-8C698DA826A0

Q38819072-ACB11F8A-28E4-4CAE-885D-61FA3FBC0DF8

Q38819072-B3071616-EA08-4A6C-8217-8559EA7EC1E7

P31

Q38819072-3058EEEA-DB8B-4CD4-959B-CD70E0B00F50

P356

Q38819072-CD02ADA2-6540-4EC5-B2CD-4C59F25DDA1F

P50

Q38819072-1EDC1499-3C22-432B-B1A9-E3A3073C4328

P577

Q38819072-DD4CE287-6F43-4063-AC51-7269DEB57BFF

P698

Q38819072-2C95EE4F-99B1-42C3-85CE-910A6C6C4B34

P356

P1433

Future Medicinal Chemistry

P1476

Is imatinib a prototypical example of targeted drug therapy?

@en

P2093

Gerald Maggiora

http://www.w3.org/2001/XMLSchema#string

P2860

A brief history of macromolecular crystallography, illustrated by a family tree and its Nobel fruits

STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data

Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy

Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism

Clinical development success rates for investigational drugs.

Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period.

Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

The evolution of molecular biology.

Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.

P31

scholarly article

P356

10.4155/FMC-2016-0145

http://www.w3.org/2001/XMLSchema#string

P50

Gerry M. Maggiora

P577

2016-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27652825

http://www.w3.org/2001/XMLSchema#string